News from the FDA/CDC

Children aged 12-15 years continue to close COVID-19 vaccination gap


 

More children aged 12-15 years already have received at least one dose of a COVID-19 vaccine than have 16- and 17-year-olds, based on data from the Centers for Disease Control and Prevention.

Proportion of children with at least one vaccine dose by age group

As of May 30, almost 2.89 million children aged 12-15 years had received at least one dose, compared with nearly 2.73 million children aged 16-17, with those figures representing increases of 31.6% and 6.6% in the past week, respectively. Since the overall size of the 12-15 population is much larger, however, the proportion vaccinated is still smaller: 19.5% to 36.4%, according to the CDC’s COVID Data Tracker.

A look at full vaccination status shows that only 0.7% of those aged 12-15 years have received both doses of a two-dose vaccine or one dose of the single-shot variety, compared with 24% of those aged 16-17. For the country as a whole, 50.5% of all ages have received at least one dose and 40.7% are fully vaccinated, the CDC said.

Children aged 12-15 represent the largest share of the U.S. population (23.4%) initiating vaccination in the 14 days ending May 30, while children aged 16-17 made up just 4.5% of those getting their first dose. The younger group’s later entry into the vaccination pool shows up again when looking at completion rates, though, representing just 0.4% of all Americans who reached full vaccination during that same 14-day period, compared with 4.6% of the older children, the CDC data show.

Not all states are reporting data such as age for vaccine recipients, the CDC noted, and there are other variables that affect data collection. “Demographic data ... might differ by populations prioritized within each state or jurisdiction’s vaccination phase. Every geographic area has a different racial and ethnic composition, and not all are in the same vaccination phase,” the CDC said.

Recommended Reading

HHS to inject billions into mental health, substance use disorders
Journal of Clinical Outcomes Management
ID experts dole out practical advice to help with mask confusion
Journal of Clinical Outcomes Management
COVID-19: One Patient at a Time
Journal of Clinical Outcomes Management
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
Journal of Clinical Outcomes Management
Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
Journal of Clinical Outcomes Management
COVID-19 vaccination rate rising quickly among adolescents
Journal of Clinical Outcomes Management
Pandemic colonoscopy restrictions may lead to worse CRC outcomes
Journal of Clinical Outcomes Management
Large vessel stroke linked to AstraZeneca COVID vaccine
Journal of Clinical Outcomes Management
Obstructive sleep apnea linked to COVID-19 risk
Journal of Clinical Outcomes Management
GI symptoms and chronic fatigue may persist months after COVID-19
Journal of Clinical Outcomes Management